Indian Clindamycin Exporters: Complete Supplier Ranking with Market Share — 1029 Manufacturers (2026) — TransData Nexus

Q: Who is the largest clindamycin buyer importing from India?

CARDINAL HEALTH (UNITED STATES) is the largest clindamycin importer from India with a 6.4% market share and import value of $5.8M.

Q: How many clindamycin buyers import from India?

There are 1029 active clindamycin buyers importing from India, with a combined import market of $90.2M across 7,242 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top clindamycin buyers from India?

The top 5 clindamycin buyers — CARDINAL HEALTH, EVERSANA LIFE SCIENCE SERVICES, LLC, IPD, SC, USA, AUROLOGISTICS LLC (AUROBINDO PHARMA, AUROLOGISTICS LLC AUROBINDO PHARM — together control 26.8% of total clindamycin import value from India.

Suresh Sormare

Clindamycin

India Pharmaceutical Trade Intelligence

$90.2M527 Suppliers144 CountriesHS 30042095

ExportsIndia → UNITED STATES60.9%India → KENYA5.1%

ImportsBELGIUM → India$14.3B FRANCE → India$32.3M

#1 Supplier: ENCUBE ETHICALS #1 Buyer: CARDINAL HEALTH

Market Analysis: Top Importing Countries & Their Importers

1United States

United States emerges as the first largest importing country, achieving a total trade value of $55.0M through 688 shipments. This represents a market share of 60.9% of the total market activity, demonstrating their significant presence in the industry.

Top Importers: United States has a diverse importer base, with their top importers including:

• CARDINAL HEALTH - $5.8M (10.5% of country's total business)

• EVERSANA LIFE SCIENCE SERVICES, LLC - $4.8M (8.7% of country's total business)

• IPD, SC, USA - $4.8M (8.7% of country's total business)

• AUROLOGISTICS LLC (AUROBINDO PHARMA - $4.7M (8.6% of country's total business)

• AUROLOGISTICS LLC AUROBINDO PHARM - $4.1M (7.5% of country's total business)

• Rest of United States's importers - $30.8M (56.0% of country's total business)

Key Insight: United States demonstrates strong market positioning with an average shipment value of $79.9K, indicating premium pricing strategy compared to the market average of $12.5K.

United States is a key market for Clindamycin imports, representing 60.9% of total trade value.

Primary Market

Secondary Market

Buyer Segment Analysis

TransData Nexus Clindamycin buyer market intelligence

1Buyer Segment Analysis

The importation of Clindamycin from India involves various buyer segments, each with distinct purchasing behaviors:

Distributors: Entities like Cardinal Health and Eversana Life Science Services, LLC in the United States fall into this category. They procure large volumes to supply hospitals, pharmacies, and healthcare providers, often engaging in long-term contracts to ensure consistent supply chains.

Contract Manufacturers: Aurobindo Pharma, operating through AuroLogistics LLC, exemplifies this segment. They import Clindamycin as an active pharmaceutical ingredient (API) for formulation into finished products, focusing on cost-effective sourcing and maintaining quality standards.

Re-exporters: Companies like Legend Creatives Co. Ltd. in Myanmar may act as intermediaries, importing Clindamycin for distribution to neighboring regions, leveraging strategic geographic positions to serve broader markets.

Each segment's purchasing patterns are influenced by their operational focus, regulatory compliance requirements, and market demand dynamics.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Country-Specific Import Regulations

TransData Nexus Clindamycin buyer market intelligence

1Country-Specific Import Regulations

United States

1. Regulatory Authority: Food and Drug Administration (FDA).

2. Import Registration Process: Importers must file an entry notice and bond with U.S. Customs. The FDA reviews the entry, and if necessary, inspects the shipment. Products must comply with the Federal Food, Drug, and Cosmetic Act.

3. Estimated Timeline: The review process varies; if no inspection is required, clearance can be swift. If inspection is needed, it may extend the timeline.

4. Import Tariff/Duty: Pharmaceutical products under HS Code 30042095 are generally duty-free in the U.S.

Kenya

1. Regulatory Authority: Pharmacy and Poisons Board (PPB).

2. Import Registration Process: Importers must obtain a marketing authorization from the PPB, which includes dossier submission, product evaluation, and approval.

3. Estimated Timeline: The registration process can take several months, depending on the completeness of the application and the PPB's review schedule.

4. Import Tariff/Duty: Pharmaceuticals are typically subject to a 0% import duty in Kenya.

Philippines

1. Regulatory Authority: Food and Drug Administration Philippines.

2. Import Registration Process: Requires a Certificate of Product Registration (CPR), involving submission of technical documents, product samples, and payment of fees.

3. Estimated Timeline: The process may take 6 months to a year, depending on the product's risk classification and the FDA's workload.

4. Import Tariff/Duty: Pharmaceuticals under HS Code 30042095 are generally exempt from import duties.

Myanmar

1. Regulatory Authority: Food and Drug Administration Myanmar.

Demand Drivers & Market Opportunity

TransData Nexus Clindamycin buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Clindamycin in importing countries is driven by several factors:

Disease Prevalence: Clindamycin is essential for treating bacterial infections, including skin infections, respiratory tract infections, and certain types of pneumonia. High prevalence of these conditions increases demand.

Government Healthcare Programs: Many countries have initiatives to improve access to essential medicines. For instance, the WHO's Essential Medicines List includes Clindamycin, guiding national procurement strategies.

Universal Health Coverage Expansion: Efforts to achieve universal health coverage lead to increased procurement of essential antibiotics like Clindamycin to meet public health needs.

Tender-Based Purchasing: Public sector procurement often involves competitive tendering, ensuring cost-effective acquisition of medicines.

With 1,029 buyers across 144 countries, the global market for Clindamycin reflects its critical role in healthcare systems worldwide.

Common Questions — Clindamycin Buyers & Importers

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

QWho is the largest clindamycin buyer importing from India?

Based on import volume and value, CARDINAL HEALTH (UNITED STATES) leads with $5.8M in imports and a 6.4% market share — the highest of any single clindamycin importer. EVERSANA LIFE SCIENCE SERVICES, LLC (UNITED STATES) and IPD, SC, USA (UNITED STATES) are the next largest buyers.

QHow many companies buy clindamycin from India?

There are 1029 active clindamycin buyers importing from India, with a combined market of $90.2M across 7,242 shipments to 144 countries. The top 5 buyers hold 26.8% of total import value, while the remaining 1024 buyers handle the other 73.2%.

QWhich countries import the most clindamycin from India?

The top importing countries for clindamycin from India are United States (60.9%), Kenya (5.1%), Philippines (4.0%), Myanmar (3.4%), Canada (2.3%). These markets represent the largest demand centres for Indian pharmaceutical exports of clindamycin, with buyers ranging from government procurement agencies to private pharmaceutical distributors.

QWhat is the average import order value for clindamycin from India?

The average import transaction value for clindamycin from India is , with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.

Buyer Segment Analysis

TransData Nexus Clindamycin buyer market intelligence

1Buyer Segment Analysis

The importation of Clindamycin from India involves various buyer segments, each with distinct purchasing behaviors:

Distributors: Entities like Cardinal Health and Eversana Life Science Services, LLC in the United States fall into this category. They procure large volumes to supply hospitals, pharmacies, and healthcare providers, often engaging in long-term contracts to ensure consistent supply chains.

Contract Manufacturers: Aurobindo Pharma, operating through AuroLogistics LLC, exemplifies this segment. They import Clindamycin as an active pharmaceutical ingredient (API) for formulation into finished products, focusing on cost-effective sourcing and maintaining quality standards.

Re-exporters: Companies like Legend Creatives Co. Ltd. in Myanmar may act as intermediaries, importing Clindamycin for distribution to neighboring regions, leveraging strategic geographic positions to serve broader markets.

Each segment's purchasing patterns are influenced by their operational focus, regulatory compliance requirements, and market demand dynamics.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Country-Specific Import Regulations

TransData Nexus Clindamycin buyer market intelligence

1Country-Specific Import Regulations

United States

1. Regulatory Authority: Food and Drug Administration (FDA).

3. Estimated Timeline: The review process varies; if no inspection is required, clearance can be swift. If inspection is needed, it may extend the timeline.

4. Import Tariff/Duty: Pharmaceutical products under HS Code 30042095 are generally duty-free in the U.S.

Kenya

1. Regulatory Authority: Pharmacy and Poisons Board (PPB).

2. Import Registration Process: Importers must obtain a marketing authorization from the PPB, which includes dossier submission, product evaluation, and approval.

3. Estimated Timeline: The registration process can take several months, depending on the completeness of the application and the PPB's review schedule.

4. Import Tariff/Duty: Pharmaceuticals are typically subject to a 0% import duty in Kenya.

Philippines

1. Regulatory Authority: Food and Drug Administration Philippines.

2. Import Registration Process: Requires a Certificate of Product Registration (CPR), involving submission of technical documents, product samples, and payment of fees.

3. Estimated Timeline: The process may take 6 months to a year, depending on the product's risk classification and the FDA's workload.

4. Import Tariff/Duty: Pharmaceuticals under HS Code 30042095 are generally exempt from import duties.

Myanmar

1. Regulatory Authority: Food and Drug Administration Myanmar.

Demand Drivers & Market Opportunity

TransData Nexus Clindamycin buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Clindamycin in importing countries is driven by several factors:

Disease Prevalence: Clindamycin is essential for treating bacterial infections, including skin infections, respiratory tract infections, and certain types of pneumonia. High prevalence of these conditions increases demand.

Government Healthcare Programs: Many countries have initiatives to improve access to essential medicines. For instance, the WHO's Essential Medicines List includes Clindamycin, guiding national procurement strategies.

Universal Health Coverage Expansion: Efforts to achieve universal health coverage lead to increased procurement of essential antibiotics like Clindamycin to meet public health needs.

Tender-Based Purchasing: Public sector procurement often involves competitive tendering, ensuring cost-effective acquisition of medicines.

With 1,029 buyers across 144 countries, the global market for Clindamycin reflects its critical role in healthcare systems worldwide.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Clindamycin

Clindamycin

Who Buys Clindamycin from India — 1029 Importers Behind a $90.2M Market

Top Clindamycin Importers — Ranked by Import Value

Top Clindamycin Buyers & Importers

Related Analysis

Need Details?

Clindamycin — Export Intelligence Video

Market Analysis: Top Importing Countries & Importers

Which companies are buying Clindamycin — and from which countries?

Clindamycin — Buyer Countries to Key Importers

Market Analysis: Top Importing Countries & Their Importers

1United States

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Common Questions — Clindamycin Buyers & Importers

QWho is the largest clindamycin buyer importing from India?

QHow many companies buy clindamycin from India?

QWhich countries import the most clindamycin from India?

QWhat is the average import order value for clindamycin from India?

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

2Kenya

3Philippines

4Myanmar

5Canada

Analysis Methodology